Evidence map›Paper›PMID 26042420›Full record

Trial reportPloS one2015

Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus.

Anna L Mitchell, Anette Bøe Wolff, Katie MacArthur, Jolanta U Weaver, Bijay Vaidya, Swedish Addision Registry Study Group, Sophie Bensing on behalf of The Swedish Addison Registry Study Group, Martina M Erichsen, Rebecca Darlay, Eystein S Husebye and 2 more

Erratum issuedOpen access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults.Journal of endocrinological investigation · 2019
    Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Anna L MitchellInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Anette Bøe WolffDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Katie MacArthurInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Jolanta U WeaverInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Bijay VaidyaRoyal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.
Swedish Addision Registry Study Group
Sophie Bensing on behalf of The Swedish Addison Registry Study Group
Martina M ErichsenDepartment of Medicine, Haukeland University Hospital, Bergen, Norway.
Rebecca DarlayInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Eystein S HusebyeDepartment of Clinical Science, University of Bergen, Bergen, Norway; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Heather J CordellInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Simon H S PearceInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Newcastle University · GBHaukeland University Hospital · NORoyal Devon & Exeter NHS Foundation Trust · GBUniversity of Bergen · NO

Funding

Medical Research Council G0701632Medical Research Council G0900001Medical Research Council G0900390Medical Research Council MR/J002526/1
6 · The paper itself

Abstract

backgroundAutoimmune Addison's disease (AAD) is a rare, highly heritable autoimmune endocrinopathy. It is possible that there may be some highly penetrant variants which confer disease susceptibility that have yet to be discovered.

methodsDNA samples from 23 multiplex AAD pedigrees from the UK and Norway (50 cases, 67 controls) were genotyped on the Affymetrix SNP 6.0 array. Linkage analysis was performed using Merlin. EMMAX was used to carry out a genome-wide association analysis comparing the familial AAD cases to 2706 UK WTCCC controls. To explore some of the linkage findings further, a replication study was performed by genotyping 64 SNPs in two of the four linked regions (chromosomes 7 and 18), on the Sequenom iPlex platform in three European AAD case-control cohorts (1097 cases, 1117 controls). The data were analysed using a meta-analysis approach.

resultsIn a parametric analysis, applying a rare dominant model, loci on chromosomes 7, 9 and 18 had LOD scores >2.8. In a non-parametric analysis, a locus corresponding to the HLA region on chromosome 6, known to be associated with AAD, had a LOD score >3.0. In the genome-wide association analysis, a SNP cluster on chromosome 2 and a pair of SNPs on chromosome 6 were associated with AAD (P <5x10-7). A meta-analysis of the replication study data demonstrated that three chromosome 18 SNPs were associated with AAD, including a non-synonymous variant in the NFATC1 gene.

conclusionThis linkage study has implicated a number of novel chromosomal regions in the pathogenesis of AAD in multiplex AAD families and adds further support to the role of HLA in AAD. The genome-wide association analysis has also identified a region of interest on chromosome 2. A replication study has demonstrated that the NFATC1 gene is worthy of future investigation, however each of the regions identified require further, systematic analysis.

Indexed as

Genetic LinkageGenetic LociGenetic Predisposition to DiseasePolymorphism, Single NucleotideAddison DiseaseAdolescentAdultAgedChildChromosomes, Human, Pair 18Chromosomes, Human, Pair 2Chromosomes, Human, Pair 7Cohort StudiesGenome-Wide Association StudyHumansMaleNFATC1 protein, humanNFATC Transcription Factors

Identifiers

PMID26042420
PMCPMC4456164
OpenAlexW1572709110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.